Condition

Immune Checkpoint Therapy clinical trials and research

• 7Clinical trials
• 2Countries

Newest Immune Checkpoint Therapy clinical trials

All recruiting trials (7)

• Node-sparing low-dose radiotherapy combined with chemotherapy and PD-1 blocker for high-risk pMMR/MSS locally advanced colon cancer.

  This trial tests whether adding node-sparing low-dose radiotherapy to standard chemotherapy and a PD-1 blocker can improve tumor response in adults with high-risk, locally advanced pMMR/MSS colon cancer before surgery.

  Recruiting Phase 2 Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07279077

• Node-sparing hypofractionated radiotherapy with chemotherapy and PD-1 blockade for high-risk MSS/pMMR locally advanced colon cancer

  This trial will test whether node-sparing, short-course radiotherapy combined with chemotherapy and a PD-1 blocker can improve pre-surgery tumor response in adults with high-risk, microsatellite-stable (pMMR/MSS) locally advanced colon cancer.

  Recruiting Phase 2 Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07230639

• Node-sparing radiotherapy with chemotherapy and PD-1 inhibitor for rectal cancer

  This study is testing a new treatment for mid-low rectal cancer that combines special radiation, chemotherapy, and an immune booster to see if it helps patients respond better while protecting their lymph nodes.

  Recruiting Phase 2/3 Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT06958432

• Combining node-sparing radiotherapy with chemotherapy and immunotherapy for metastatic colorectal cancer

  This study is testing a new treatment that combines a special type of radiation with chemotherapy and immunotherapy to see if it can help people with metastatic colorectal cancer live longer and feel better.

  Recruiting Phase 2/3 Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT06958419

• Combining long-course radiotherapy, chemotherapy, and PD-1 inhibitor for high-risk rectal cancer

  This study is testing a new treatment plan that combines radiation, chemotherapy, and a PD-1 inhibitor to see if it helps people with high-risk rectal cancer do better than with standard treatments.

  Recruiting Phase 2 Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT06923345

• Testing a blood test to predict response to cancer immunotherapy

  This study is testing a blood test to see if it can predict how well people with advanced cancer will respond to a specific type of immunotherapy.

  Recruiting at 3 sites Oxford Biodynamics Inc. · Norwich, Connecticut and 2 other locations · NCT06635954

• Monitoring heart injury in cancer patients receiving immune checkpoint therapy

  This study tests if checking blood levels of a heart injury marker can help cancer patients on immune checkpoint therapy avoid heart problems and improve their treatment experience.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT06337097

Related topics

Quick answers

How many Immune Checkpoint Therapy clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (5 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →